Santen Pharmaceutical has signed a licensing agreement with RemeGen for the RC28-E intravitreal injection, a dual-target fusion protein designed to treat retinal diseases. The agreement, facilitated ...
YANTAI, China, Aug. 19, 2025 /PRNewswire/ -- RemeGen Co., Ltd. (Stock Code: 688331.SH/09995.HK, "RemeGen"), a leading Chinese biopharmaceutical company, announced ...
In this brave new world of disc brakes and thru axles it's easy to forget that the majority of us are still riding standard road bikes with conventional rim brakes. DT Swiss has been as big a ...
YANTAI, China, Aug. 18, 2025 /PRNewswire/ -- RemeGen Co., Ltd. (Stock Code: SH/09995, "RemeGen"), a leading Chinese biopharmaceutical company, announced today that it has entered into an agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results